All In Biotech

Drug Trial Radar · NCT05624424

Effect of Rematazolam Besylate, Propofol, and Sevoflurane Perioperative Sedation on Incidence of Emergence Agitation and Hemodynamics in Patients Undergoing Laparoscopic Abdominal Surgery

Last checked: Nov 19, 2026Latest source record: Nov 22, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 1,317 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

1,317

Planned (sponsor's estimate)

Start

Nov 15, 2022

Primary completion

Oct 31, 2023

Study completion Oct 31, 2023

Sponsor

Lead sponsor
Second Affiliated Hospital of Nanchang UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Yichang Humanwell Pharmaceutical Co., Ltd., China
First posted
Nov 22, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Emergence agitation (EA) is a transient, self-limited, non-fluctuating state of psychomotor excitement, which closely revolves around the emergence of general anesthesia. Uncontrolled EA during the recovery period increases the potential risk of injury to patients and medical staff, resulting in varying degrees of adverse consequences, such as elevated blood pressure, incision rupture, bleeding, cardio-cerebrovascular accidents and so on, leading to a great waste of resources. Accumulating scientific evidence indicates that the incidence of EA is related to the use of perioperative sedative drugs. As a novel ultra-short-acting benzodiazepines drugs, Remimazolam has been accepted for induction and maintenance of clinical anesthesia. Compared to traditional benzodiazepines drugs, Remimazolam combines the safety of midazolam with the effectiveness of propofol, and also has the advantages of acting quickly, short half-life, no injection pain, slight respiratory depression, independent of liver and kidney metabolism, long-term infusion without accumulation, and has a specific antagonist: flumazenil. This study aims to investigate whether perioperative sedation of Remimazolam besylate, propofol, and sevoflurane have different effects on the incidence of emergence agitation and hemodynamics in patients undergoing laparoscopic abdominal surgery.

Conditions

  • Emergence Agitation
  • Remimazolam Besylate
  • Perioperative Sedation
  • Laparoscopic Abdominal Surgery
  • Anesthesia, General

Interventions

  • Rematazolam BesylateDrug

    Anesthesia was induced with Rematazolam Besylate 0.3\~0.5 mg/kg (about 1 minute) by intravenous injection until the loss of consciousness (LoC) and BIS\<60, followed by remimazolam 1-3 mg/kg/h until the end of surgery.

  • PropofolDrug

    Anesthesia was induced with Propofol 2\~2.5 mg/kg (about 1 minute) by intravenous injection until the loss of consciousness (LoC) and BIS\<60, followed by remimazolam 5\~12 mg/kg/h until the end of surgery.

  • SevofluraneDrug

    Anesthesia was induced with etomidate 0.03 mg/kg (about 1 minute) by intravenous injection until the loss of consciousness (LoC) and BIS\<60, followed by 2 %-3 % Sevoflorane until the end of surgery.

  • SufentanilDrug

    Anesthesia was induced with Sufentanil 0.3\~0.5 ug/kg by intravenous injection after the LoC and BIS\<60.

  • Cisatracurium BesylateDrug

    Anesthesia was induced with cisatracurium besilate 0.2-0.3 mg/kg by intravenous injection after the LoC and BIS\<60, followed by 0.1 mg/kg/h Cisatracurium Besylate during the operation.

  • RemifentanilDrug

    After the LoC, remifentanil 0.1\~0.3 ug/kg/min inject intravenously until the end of surgery.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The incidence of emergence agitationTime frame: Duration from the time patients awakening to the time of departure from post-anesthesia care unit (PACU), average 1 hour.
  2. The incidence of emergence agitationTime frame: Duration from the time patients awakening to the time of departure from PACU, average 1 hour.

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • People's Hospital of Ganzhou

    Ganzhou, Jiangxi, China

  • the First Affiliated Hospital of Gannan Medical College, Gannan Medical College

    Ganzhou, Jiangxi, China

  • The First People's Hospital of JiuJiang

    Jiujiang, Jiangxi, China

  • the Second Affiliated Hospital of Nanchang University, Nanchang University

    Nanchang, Jiangxi, China

  • Tumor Hospital of Jiangxi Province

    Nanchang, Jiangxi, China

  • Shangrao People's Hospital

    Shangrao, Jiangxi, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.